Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases
- PMID: 16010459
- DOI: 10.1007/s11102-005-1050-3
Pituitary apoplexy: a review of clinical presentation, management and outcome in 45 cases
Abstract
Objective: To review clinical presentation, management and outcomes following different therapies in patients with pituitary apoplexy.
Methods: Retrospective analysis of case-records of patients with classical pituitary apoplexy treated in our hospitals between 1983-2004.
Results: Forty-five patients (28 men; mean age 49 years, range 16-72 years) were identified. Only 8 (18%) were known to have pituitary adenomas at presentation. Thirty-four (81%) patients had hypopituitarism at presentation. CT and MRI identified pituitary apoplexy in 28% and 91% cases, respectively. Twenty-seven (60%) patients underwent surgical decompression, whilst 18 (40%) were managed conservatively. Median time from presentation to surgery was 6 days (range 1-121 days). Patients with visual field defects were more likely than those without these signs to be managed surgically (p = 0.01). Complete or near-complete resolution occurred in 93% (13/14), 94% (15/16) and 93% (13/14) of the surgically treated patients with reduced visual acuity, visual field deficit and ocular palsy, respectively. All patients with reduced visual acuity (4/4), visual field deficit (4/4) and ocular palsy (8/8) in the conservative group had complete or near-complete recovery. Only 5 (19%) patients in the surgical group and 2 (11%) in the conservative group had normal pituitary function at follow up. One (4%) patient in the surgical group and 4 (22%) in the conservative group had a recurrence of pituitary adenoma.
Conclusions: This large series suggests that the patients with classical pituitary apoplexy, who are without neuro-ophthalmic signs or exhibit mild and non-progressive signs, can be managed conservatively in the acute stage.
Similar articles
-
Management and outcomes of pituitary apoplexy.J Neurosurg. 2015 Jun;122(6):1450-7. doi: 10.3171/2014.10.JNS141204. Epub 2015 Apr 10. J Neurosurg. 2015. PMID: 25859804
-
Management of pituitary apoplexy: clinical experience with 40 patients.Acta Neurochir (Wien). 2005 Feb;147(2):151-7; discussion 157. doi: 10.1007/s00701-004-0413-2. Acta Neurochir (Wien). 2005. PMID: 15570437
-
Presentation, management and outcomes in acute pituitary apoplexy: a large single-centre experience from the United Kingdom.Clin Endocrinol (Oxf). 2014 Mar;80(3):419-24. doi: 10.1111/cen.12307. Epub 2013 Aug 26. Clin Endocrinol (Oxf). 2014. PMID: 23909507
-
Pituitary Apoplexy: Results of Surgical and Conservative Management Clinical Series and Review of the Literature.World Neurosurg. 2019 Oct;130:e988-e999. doi: 10.1016/j.wneu.2019.07.055. Epub 2019 Jul 11. World Neurosurg. 2019. PMID: 31302273 Review.
-
Surgical treatment of pituitary apoplexy in association with hemispheric infarction.J Clin Neurosci. 2015 Oct;22(10):1550-4. doi: 10.1016/j.jocn.2015.03.049. Epub 2015 Jul 23. J Clin Neurosci. 2015. PMID: 26213287 Review.
Cited by
-
Unveiling postpartum pituitary apoplexy through atypical presentation: A case report and review of literature.Radiol Case Rep. 2024 Oct 25;20(1):272-277. doi: 10.1016/j.radcr.2024.09.138. eCollection 2025 Jan. Radiol Case Rep. 2024. PMID: 39525919 Free PMC article.
-
The role of intervention timing and treatment modality in visual recovery following pituitary apoplexy: a systematic review and meta-analysis.J Neurooncol. 2024 Nov 6. doi: 10.1007/s11060-024-04717-z. Online ahead of print. J Neurooncol. 2024. PMID: 39503840 Review.
-
Pituitary apoplexy: a comprehensive analysis of 93 cases across functioning and non-functioning pituitary adenomas from a single-center.Pituitary. 2024 Oct;27(5):705-713. doi: 10.1007/s11102-024-01453-5. Epub 2024 Sep 13. Pituitary. 2024. PMID: 39269545
-
Pituitary Apoplexy: a re-appraisal of risk factors and best management strategies in the COVID-19 era.Pituitary. 2024 Aug 5. doi: 10.1007/s11102-024-01420-0. Online ahead of print. Pituitary. 2024. PMID: 39102126 Review.
-
Pituitary Apoplexy: Description of Medical and Surgical Treatment and Clinical, Visual, and Endocrinological Outcomes During the SARS-CoV-2 Pandemic and Over Three Years.Cureus. 2024 Jun 25;16(6):e63152. doi: 10.7759/cureus.63152. eCollection 2024 Jun. Cureus. 2024. PMID: 39055441 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources